West Virginians Top GLP-1 Prescriptions
- WEST VIRGINIA (WCHS) — GLP-1 agonists, a class of drugs including popular medications like Ozempic, Wegovy, and Mounjaro, are increasingly used for weight loss and diabetes management.
- This high rate is attributed to several factors, including the state's position in what is referred to as the "diabetic belt" of the United States.
- West Virginia has consistently ranked among the most obese and unhealthy states,often appearing in the top 10 based on CDC data.
GLP-1 Agonists: High Usage in West Virginia, benefits Highlighted
Table of Contents
- GLP-1 Agonists: High Usage in West Virginia, benefits Highlighted
- The Rise of GLP-1 Agonists in West Virginia
- Health Benefits and Encouraging Results
- Understanding GLP-1 Medications: Types and Functions
- The Role of GLP-1 Agonists in Managing Blood Sugar
- Patient Experience and Medication Effects
- Cost and Insurance Coverage Challenges
- Critically important Considerations When Using GLP-1 Agonists
- GLP-1 Agonists: Your Questions Answered
- What are GLP-1 agonists?
- Which Medications are Considered GLP-1 Agonists?
- How Do GLP-1 Agonists Work?
- What are the Health Benefits of GLP-1 Agonists?
- What is the Significance of GLP-1 Agonist Usage in West Virginia?
- What are the Reported Patient Experiences with GLP-1 Medications?
- what are the Potential Drawbacks of GLP-1 Agonists?
- Important Considerations when Using GLP-1 Agonists
- GLP-1 Agonist Medication Comparison
published: 2025-03-08
The Rise of GLP-1 Agonists in West Virginia
WEST VIRGINIA (WCHS) — GLP-1 agonists, a class of drugs including popular medications like Ozempic, Wegovy, and Mounjaro, are increasingly used for weight loss and diabetes management. A 2024 study by Whitley Law Firm revealed that West Virginia has the highest usage rate in the nation. over 24,000 West virginians per 100,000 residents have been prescribed these medications.
This high rate is attributed to several factors, including the state’s position in what is referred to as the “diabetic belt” of the United States.
We tend to be in the diabetic belt. And so to speak of the United States. We have a high obesity rate. And due to inactivity, our diet, our culture, things of that nature. And it does help with that tremendously.
Alice lockman,family nurse practitioner
Health Benefits and Encouraging Results
West Virginia has consistently ranked among the most obese and unhealthy states,often appearing in the top 10 based on CDC data. Healthcare professionals are turning to weight loss medications like GLP-1 agonists to combat the associated negative health effects. The outcomes observed in patients using these drugs have been notably positive.
we do quite a bit here. We have seen our a1c’s lowered drastically patients have gotten healthier so I think it’s a great thing.
Jack Whitley, pharmacist
Understanding GLP-1 Medications: Types and Functions
GLP-1 agonists encompass a variety of medications. Ozempic and Mounjaro are commonly prescribed for individuals with diabetes, while Wegovy and Zepbound are primarily used for weight loss. Additionally,compounded versions of these drugs,such as semaglutide and tirzepatide,are available through compounding pharmacies.
These medications offer a range of health benefits beyond just weight management.
They have done a lot of studies that it lowers the risk of cardiac disease, renal disease and obesity as there’s not as much workload on the heart. But Ozempic is the one that a lot of people do use.
Alice Lockman, family nurse practitioner
GLP-1 agonists work by creating a feeling of fullness, wich reduces overall calorie intake and leads to weight loss. They also aid in the body’s natural insulin production or enhance its ability to utilize insulin effectively.
According to Wikipedia, GLP-1 agonists work by activating the GLP-1 receptor. “they slow gastric emptying, inhibit the release of glucagon, and stimulate insulin production, thus reducing hyperglycemia in people with type 2 diabetes. They also reduce food intake and thus body weight, making them an effective treatment for obesity.”
The Role of GLP-1 Agonists in Managing Blood Sugar
One of the key functions of GLP-1 receptor agonists is their ability to regulate blood sugar levels. By stimulating insulin production and reducing glucagon release, these medications help lower hyperglycemia in individuals with type 2 diabetes.
Patient Experience and Medication Effects
Patients often report positive experiences with GLP-1 medications, noting improvements in various health markers.
It keeps people full longer. So therefore, they don’t want to eat as much. And it helps to lower their A1C. It helps to lower their blood pressure. It makes them feel better to know that they’re losing weight. It’s an excellent medication.
Alice Lockman, family nurse practitioner
Cost and Insurance Coverage Challenges
Despite their benefits, GLP-1 agonists can be expensive, with costs ranging from $900 to over $1,400 per month, depending on the specific medication, according to The American Journal of Managed Care.Insurance coverage is not always guaranteed, especially when the medication is prescribed solely for weight loss.
This lack of coverage presents a significant barrier for many patients.
I would hope that Medicaid and Medicare, we have to do prior authorizations for them, which can be pretty tedious.And we’re hoping that they’ll open up those gates and let us have those medications more freely. So we don’t have to jump through those hoops.
Alice Lockman, family nurse practitioner
Critically important Considerations When Using GLP-1 Agonists
- pregnancy: If you become pregnant while taking a GLP-1 agonist, it is indeed crucial to contact your healthcare provider immediately.
- Hypoglycemia: There is a low risk of mild low blood sugar (hypoglycemia) episodes when taking a GLP-1 agonist.This risk can become serious if combined with other medications that lower blood sugar, such as sulfonylureas or insulin.
- Monitoring: According to Gateshead Health, specific monitoring after starting oral Semaglutide is not typically required.
- Driving and DVLA Regulations: The need for DVLA notification depends on your medication regimen,the type of driving license you hold (group 1 or group 2),and other individual factors. Consult with your healthcare provider for personalized advice.
GLP-1 Agonists: Your Questions Answered
GLP-1 (Glucagon-Like Peptide-1) agonists are gaining prominence in managing type 2 diabetes and obesity. This article addresses common questions about these medications, their benefits, and crucial considerations for their use.
What are GLP-1 agonists?
GLP-1 agonists are a class of medications that mimic the effects of the naturally occurring GLP-1 hormone in the body. They help regulate blood sugar levels and promote weight loss.
Which Medications are Considered GLP-1 Agonists?
Commonly prescribed GLP-1 agonists include:
Ozempic (semaglutide)
Wegovy (semaglutide)
Mounjaro (tirzepatide)
Zepbound (tirzepatide)
Semaglutide (compounded)
Tirzepatide (compounded)
Ozempic and Mounjaro are primarily prescribed for individuals with type 2 diabetes, while Wegovy and Zepbound are mainly used for weight loss. Compounded versions of semaglutide and tirzepatide are also available.
How Do GLP-1 Agonists Work?
GLP-1 agonists work through several mechanisms:
Slowing Gastric Emptying: This leads to a feeling of fullness, reducing overall calorie intake.
Inhibiting Glucagon Release: Glucagon raises blood sugar levels; by inhibiting its release, GLP-1 agonists help lower blood sugar.
Stimulating Insulin Production: They enhance the body’s natural insulin production or improve its ability to use insulin effectively, reducing hyperglycemia in people with type 2 diabetes.
What are the Health Benefits of GLP-1 Agonists?
Beyond weight loss and blood sugar control, GLP-1 agonists offer several health benefits:
Reduced Risk of Cardiac Disease: Studies have shown that these medications can lower the risk of cardiovascular issues.
Reduced Risk of Renal Disease: GLP-1 agonists can help protect kidney function.
What is the Significance of GLP-1 Agonist Usage in West Virginia?
A 2024 study by Whitley Law Firm revealed that West Virginia has the highest usage rate of GLP-1 agonists in the nation, with over 24,000 West Virginians per 100,000 residents being prescribed these medications. This high rate is attributed to the state’s high obesity rate and position in the “diabetic belt” of the United States.
What are the Reported Patient Experiences with GLP-1 Medications?
Patients often report positive experiences with GLP-1 medications, including:
Improved A1C levels (a measure of average blood sugar)
Lower blood pressure
Overall feeling of better health due to weight loss
Reduced appetite and increased satiety
what are the Potential Drawbacks of GLP-1 Agonists?
Despite their benefits, GLP-1 agonists also have potential drawbacks:
Cost: These medications can be expensive, ranging from $900 to over $1,400 per month, depending on the specific drug.
Insurance Coverage: Insurance coverage is not always guaranteed, especially when prescribed solely for weight loss.
Important Considerations when Using GLP-1 Agonists
Pregnancy
If you become pregnant while taking a GLP-1 agonist, contact your healthcare provider promptly.
hypoglycemia
There is a low risk of mild low blood sugar (hypoglycemia) episodes when taking a GLP-1 agonist. This risk can become serious if combined with other medications that lower blood sugar,such as sulfonylureas or insulin.
Monitoring
According to Gateshead Health, specific monitoring after starting oral Semaglutide is not typically required.
Driving and DVLA Regulations
The need for DVLA notification depends on your medication regimen, the type of driving license you hold (group 1 or group 2), and other individual factors. Consult with your healthcare provider for personalized advice.
GLP-1 Agonist Medication Comparison
| Medication | Primary Use | Potential Side Effects | Cost (Estimated) | Administration |
| :——— | :————— | :———————————————— | :————— | :———————— |
| Ozempic | Type 2 Diabetes | Nausea, diarrhea, vomiting, constipation, abdominal pain | $900 – $1400+ | Weekly injection |
| wegovy | Weight Loss | Nausea, diarrhea, vomiting, constipation, abdominal pain | $900 – $1400+ | Weekly injection |
| Mounjaro | Type 2 Diabetes | Nausea, diarrhea, vomiting, constipation, abdominal pain | $900 – $1400+ | Weekly injection |
| Zepbound | Weight Loss | Nausea, diarrhea, vomiting, constipation, abdominal pain | $900 – $1400+ | Weekly injection |
Note: Costs are estimates and can vary based on location, insurance coverage, and pharmacy.*